BioSpace News Archive

FDA

Clinical Trial Application (IND) for BioRay Pharmaceutical’s BR105 Injection Receives U.S. FDA Approval

BioRay Pharmaceutical Co., Ltd. announced on October 7th that its clinical trial application for BR105 Injection has received approval from the United States Food and Drug Administration.

October 24, 2023
·
2 min read
Turbine Establishes Research Collaboration with Ono Pharmaceutical to Identify and Validate Novel Oncology Targets

Turbine, a computational biology company that deploys empirically validated in silico cell simulations to guide biopharma R&D, announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd to identify and validate novel targets within one of Ono’s priority domains of cancer biology.

October 24, 2023
·
4 min read
Drug Development

Genascence to Present Full Data from Phase 1 Clinical Trial on GNSC-001, Company’s Lead Program in Osteoarthritis, at European Society of Gene & Cell Therapy 30th Annual Congress

Genascence Corporation announced that data from the Phase 1 clinical trial of GNSC-001 for the treatment of osteoarthritis demonstrated that it was safe and well tolerated.

October 24, 2023
·
5 min read
Policy

Endogena Therapeutics Secures FDA Green Light for Breakthrough AMD Treatment

Endogena Therapeutics Inc., a pioneering biotech company dedicated to revolutionizing regenerative medicine, is proud to announce a significant achievement that holds the promise of transforming lives.

October 24, 2023
·
3 min read
Drug Development

ImmunOs Therapeutics Presents Overview of Phase 1a/b Trial of Lead Compound IOS-1002

ImmunOs Therapeutics AG, a biopharmaceutical company pioneering HLA-based therapeutics to create transformational medicines for cancer and inflammation, announced an update on the ongoing Phase 1a/b trial of its lead program IOS-1002 in Australia.

October 24, 2023
·
3 min read
Life Molecular Imaging and Sinotau Pharmaceutical Group Announce the Regulatory Approval of their Amyloid PET Imaging Radiopharmaceutical Neuraceq® in China

Life Molecular Imaging and Sinotau Pharmaceutical Group are pleased to announce Neuraceq® has received regulatory approval from National Medical Products Administration in China.

October 24, 2023
·
7 min read
Jefferies to Host 14th Annual Global Healthcare Conference in London

Jefferies looks forward to welcoming delegates back to its 2023 London Healthcare Conference, taking place in-person from Tuesday, November 14 to Thursday, November 16.

October 24, 2023
·
2 min read
BioForest

ProfoundBio to Participate in the Wells Fargo 2023 Virtual Private Biotech Symposium and Piper Sandler 35th Annual Healthcare Conference

ProfoundBio announced that management will be participating in one-on-one meetings with investors at the Wells Fargo 2023 Virtual Private Biotech Symposium on Wednesday, November 1, 2023 and at the Piper Sandler 35th Annual Healthcare Conference from November 28 – November 30, 2023.

October 24, 2023
·
1 min read
Biotech Bay

Kamiyacho Neurosurgical Clinic in Japan Celebrates First Brain Tumor Patient Treated with the New ZAP-X® Gyroscopic Radiosurgery® Platform

ZAP Surgical, a leading innovator in the field of surgical robotics, announced the first patient treatment using the groundbreaking ZAP-X® Gyroscopic Radiosurgery® platform at Kamiyacho Neurosurgical Clinic in Tokyo, Japan.

October 24, 2023
·
3 min read
Business

mbiomics Appoints Seasoned Microbiome Expert Christopher Weidenmaier as Chief Scientific Officer

mbiomics announced the appointment of Christopher Weidenmaier, PhD, as Chief Scientific Officer.

October 24, 2023
·
2 min read